A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response

Nature Communications

Volumn 3, Issue , 2012, Pages

  Chau, Jenny Fung Ling ^a,b   Jia, Deyong ^b   Wang, Zhongfeng ^b   Liu, Zhi ^a   Hu, Yuanyu ^a   Zhang, Xin ^b   Jia, Hao ^b   Lai, Keng Po ^a   Leong, Wai Fook ^a   Au, Bi Jin ^a   Mishina, Yuji ^c   Chen, Ye Guang ^d   Biondi, Christine ^e   Robertson, Elizabeth ^e   Xie, Dong ^f   Liu, Huijuan ^b   He, Lin ^b   Wang, Xueying ^g   Yu, Qiang ^h   Li, Baojie ^b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

^d TSINGHUA UNIVERSITY   (China)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DNA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN MDM2; PROTEIN P53; SMAD1 PROTEIN; ATM PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; EMBRYO DEVELOPMENT; ESOPHAGUS CANCER; GENE MUTATION; HOMEOSTASIS; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; STOMACH CANCER; UBIQUITINATION; ANIMAL; BAGG ALBINO MOUSE; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; NUDE MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NUDE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84864295500     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1832     Document Type: Article

References (58)

1. McGowan, C. H. & Russell, P. The DNA damage response: sensing and signaling. Curr. Opin. Cell Biol. 16, 629-633 (2004). (Pubitemid 39463112)
2. Harrison, J. C. & Haber, J. E. Surviving the breakup: the DNA damage checkpoint. Annu. Rev. Genet. 40, 209-235 (2006). (Pubitemid 44956785)
3. Lavin, M. F. et al. ATM signaling and genomic stability in response to DNA damage. Mutat. Res. 569, 123-132 (2005). (Pubitemid 39643262)
4. Bartek, J., Bartkova, J. & Lukas, J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26, 7773-7779 (2007). (Pubitemid 350242463)
5. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005). (Pubitemid 40558993)
6. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005). (Pubitemid 40559004)
7. Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307-310 (2000).
8. Li, B. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Endocr. Metab. Immune Disord. Drug Targets 8, 208-219 (2008).
9. Chen, D., Zhao, M. & Mundy, G. R. Bone morphogenetic proteins. Growth Factors 22, 233-241 (2004). (Pubitemid 40136452)
10. Feng, X. H. & Derynck, R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693 (2005). (Pubitemid 41740650)
11. ten Dijke, P. & Hill, C. S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29, 265-273 (2004).
12. Clarke, D. C. & Liu, X. Decoding the quantitative nature of TGF-beta/Smad signaling. Trends Cell Biol. 18, 430-442 (2008).
13. Massague, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783-2810 (2005). (Pubitemid 41739965)
14. Schmierer, B. & Hill, C. S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8, 970-982 (2007). (Pubitemid 350174642)
15. Schilling, S. H., Datto, M. B. & Wang, X. F. A phosphatase controls the fate of receptor-regulated Smads. Cell 125, 838-840 (2006). (Pubitemid 43795194)
16. Reguly, T. & Wrana, J. L. In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol. 13, 216-220 (2003). (Pubitemid 36556005)
17. Matsuura, I. et al. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430, 226-231 (2004). (Pubitemid 38902433)
18. Eivers, E., Fuentealba, L. C. & De Robertis, E. M. Integrating positional information at the level of Smad1/5/8. Curr. Opin. Genet. Dev. 18, 304-310 (2008).
19. Sapkota, G., Alarcon, C., Spagnoli, F. M., Brivanlou, A. H. & Massague, J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25, 441-454 (2007). (Pubitemid 46199289)
20. Massague, J. TGFbeta in Cancer. Cell 134, 215-230 (2008).
21. Zhou, X. P. et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am. J. Hum. Genet. 69, 704-711 (2001).
22. Kodach, L. L. et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134, 1332-1341 (2008).
23. Howe, J. R. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28, 184-187 (2001). (Pubitemid 32538067)
24. Hardwick, J. C., Kodach, L. L., Offerhaus, G. J. & van den Brink, G. R. Bone morphogenetic protein signalling in colorectal cancer. Nat. Rev. Cancer. 8, 806-812 (2008).
25. Arnold, S. J., Maretto, S., Islam, A., Bikoff, E. K. & Robertson, E. J. Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev. Biol. 296, 104-118 (2006). (Pubitemid 44061758)
26. Pangas, S. A. et al. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol. Cell Biol. 28, 248-257 (2008).
27. Ming, K. K., Li, A. G., Wang, X. J., Wurst, W. & Behringer, R. R. Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis 39, 10-25 (2004). (Pubitemid 38738012)
28. Rasheed, N., Wang, X., Niu, Q. T., Yeh, J. & Li, B. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum. Mol. Genet. 15, 1938-1948 (2006). (Pubitemid 43983268)
29. Li, B. et al. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat. Genet. 24, 304-308 (2000). (Pubitemid 30132204)
30. Wang, X. et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115-125 (2006). (Pubitemid 43042634)
31. Shiloh, Y. & Kastan, M. B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83, 209-254 (2001). (Pubitemid 32959266)
32. Kastan, M. B. & Lim, D. S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1, 179-186 (2000).
33. Kim, S. T., Lim, D. S., Canman, C. E. & Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37538-37543 (1999). (Pubitemid 30026807)
34. Chen, H. B., Shen, J., Ip, Y. T. & Xu, L. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev. 20, 648-653 (2006).
35. Lin, X. et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125, 915-928 (2006). (Pubitemid 43795197)
36. Duan, X., Liang, Y. Y., Feng, X. H. & Lin, X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J. Biol. Chem. 281, 36526-36532 (2006). (Pubitemid 46042119)
37. Knockaert, M., Sapkota, G., Alarcon, C., Massague, J. & Brivanlou, A. H. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc. Natl Acad. Sci. USA 103, 11940-11945 (2006). (Pubitemid 44215790)
38. Kokabu, S. et al. Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J. Bone Miner. Res. 25, 653-660.
39. Brooks, C. L. & Gu, W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307-315 (2006). (Pubitemid 43163526)
40. Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283 (2007). (Pubitemid 46474662)
41. Khanna, K. K. & Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247-254 (2001). (Pubitemid 32201842)
42. Mira, H. et al. Signaling through BMPR-IA regulates quiescence and long-term activity of neural stem cells in the adult hippocampus. Cell Stem Cell 7, 78-89 (2010).
43. Greco, V. et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 4, 155-169 (2009).
44. He, X. C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36, 1117-1121 (2004). (Pubitemid 41184475)
45. Zhou, B. P. et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3, 973-982 (2001). (Pubitemid 34428742)
46. Lai, K. P. et al. S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response. Embo J. 29, 2994-3006 (2010).
47. Wang, Z. & Li, B. Mdm2 links genotoxic stress and metabolism to p53. Protein Cell 1, 1063-1072 (2010).
48. Fuentealba, L. C. et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993 (2007). (Pubitemid 350138081)
49. Cordenonsi, M. et al. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113, 301-314 (2003). (Pubitemid 36556113)
50. Piccolo, S. p53 regulation orchestrates the TGF-beta response. Cell 133, 767-769 (2008). (Pubitemid 351707697)
51. Cordenonsi, M. et al. Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. Science 315, 840-843 (2007).
52. Sasai, N., Yakura, R., Kamiya, D., Nakazawa, Y. & Sasai, Y. Ectodermal factor restricts mesoderm differentiation by inhibiting p53. Cell 133, 878-890 (2008). (Pubitemid 351707684)
53. Ewan, K. B. et al. Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Res. 62, 5627-5631 (2002). (Pubitemid 35204711)
54. Zhang, S. et al. TGFbeta1-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner. Cell Cycle 5, 2787-2795 (2006). (Pubitemid 44901741)
55. Huang, S. M., Lu, K. T. & Wang, Y. C. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G arrest in cancer cells and xenograft models. Anticancer Res. 31, 203-208.
56. Chiba, N. et al. Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses. Proc. Natl Acad. Sci. USA 109, 2760-2765 (2012).
57. Wiegman, E. M., Blaese, M. A., Loeffler, H., Coppes, R. P. & Rodemann, H. P. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling. Radiother. Oncol. 83, 289-295 (2007). (Pubitemid 46907986)
58. Li, M., Luo, J., Brooks, C. L. & Gu, W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277, 50607-50611 (2002). (Pubitemid 36042220)